Understanding IGF-1 LR3 in a Research Context
IGF-1 LR3 (Long Arg3 Insulin-like Growth Factor-1) is an 83-amino-acid analog of human IGF-1. It differs from native IGF-1 in two structural ways: an arginine substitution at position 3 and an additional 13-amino-acid N-terminal extension. Together these modifications substantially reduce the peptide’s affinity for IGF-binding proteins (IGFBPs), which is the property that makes it a widely used tool in laboratory research.
Because native IGF-1 is heavily sequestered by binding proteins in biological systems, researchers investigate IGF-1 LR3 as a more bioavailable analog for probing IGF receptor signaling in controlled models, particularly in cell culture where prolonged receptor engagement is experimentally useful.
Amino Labs supplies IGF-1 LR3 as a lyophilized powder tested to 99%+ HPLC purity for research applications. Below we outline the signaling pathways researchers explore and the handling practices that help maintain the integrity of this comparatively delicate growth-factor peptide. All content is educational and framed exclusively for research settings, not for human or animal use.
Recommended Products
What Researchers Explore: IGF-1 LR3 Signaling and Mechanisms
In research models, IGF-1 LR3 is studied for its interaction with the type 1 IGF receptor (IGF-1R), a receptor tyrosine kinase. Ligand binding triggers autophosphorylation and recruitment of intracellular substrates, activating the PI3K/Akt and Ras/MAPK cascades that studies associate with cellular proliferation, differentiation, and protein synthesis signaling in preclinical systems.
The defining research feature of the LR3 analog is its reduced IGFBP affinity. Because it largely evades sequestration by IGFBP-1 through IGFBP-6, investigators observe extended receptor availability and a longer functional presence in cell-culture models compared with native IGF-1. This makes it a practical reagent for studying sustained IGF-1R activation.
Common research directions include:
- Cellular signaling studies: Characterizing downstream Akt and mTOR pathway activation in myotube, fibroblast, and other cultured cell lines.
- Metabolic and growth-axis models: Examining how IGF-1 signaling intersects with the growth hormone axis. Researchers studying upstream secretagogues often cross-reference GHRH analogs such as Sermorelin, since endogenous IGF-1 is downstream of growth hormone.
- Comparative secretagogue work: Investigators pairing growth-axis compounds may also reference CJC-1295 (No DAC) when modeling the GH-IGF-1 signaling loop.
These studies are conducted entirely in vitro or in controlled preclinical models to characterize receptor pharmacology and signaling dynamics.
Research Considerations: Handling, Reconstitution, and Storage
IGF-1 LR3 is a comparatively large and structurally sensitive peptide, so careful handling is important for maintaining bioactivity in research use.
- Lyophilized storage: Keep the sealed vial refrigerated at 2-8°C for near-term work or frozen at -20°C (or colder) for long-term storage, protected from light and moisture.
- Reconstitution: Research protocols commonly reconstitute IGF-1 LR3 with bacteriostatic water or sterile water, or with a mildly acidic diluent where a protocol specifies improved solubility. Add diluent slowly down the vial wall and swirl gently; avoid vigorous agitation, which can denature the peptide.
- After reconstitution: Store refrigerated and minimize freeze-thaw cycles, as repeated cycling accelerates degradation of growth-factor peptides. Aliquoting is a common laboratory strategy to limit repeated thawing.
Reproducible results depend on reliable sourcing. Amino Labs provides IGF-1 LR3 as a third-party tested, lyophilized product at 99%+ HPLC purity, Canadian-owned with shipping across Canada. Researchers building growth-axis panels may also review secretagogues such as Ipamorelin.